Your account is not claimed yet. You can sign up with ORCID to claim your account.

Philip N Patsalos (Philip Patsalos)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Top Venues

British journal of clinical pharmacology

Expert opinion on drug metabolism & toxicology

UCL Institute of Neurology, University College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCL Institute of Neurology, University College London

United Kingdom

Professor of Clinical Pharmacology :: Clinical and Experimental Epilepsy

Publications

Frank M C Besag, Dave Berry, Michael J Vasey, Philip N Patsalos
Drug-drug interactions between antiseizure medications and antipsychotic medications: a narrative review and expert opinion. Expert opinion on drug metabolism & toxicology (2023)
Jenna Niyongere, Timothy E Welty, Michelle W Bell, Damian Consalvo, Charles Hammond, Howan Leung, Philip N Patsalos, Melody Ryan, Thanarat Suansanae, Dong Zhou, Hazel Zuellig
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force. Epilepsia open 7 (2) (2022)
Rezzan Gülhan, Emel Eryüksel, Medine Gülçebi İdriz Oğlu, Yekta Çulpan, Aylin Toplu, Derya Kocakaya, Elif Tukenmez Tigen, Buket Ertürk Sengel, Uluhan Sili, Şehnaz Olgun Yıldızeli, Mehmet Baran Balcan, Abdullah Elçi, Cenk Bulut, Atila Karaalp, Hasan Raci Yananlı, Abdullah Emre Güner, Mustafa Hatipoğlu, Sait Karakurt, Volkan Korten, Neville Ratnaraj, Philip N Patsalos, Nadiye Pınar Ay, Filiz Onat
Pharmacokinetic characterization of favipiravir in patients with COVID-19. British journal of clinical pharmacology 88 (7) (2022)
Philip N Patsalos, Jerzy P Szaflarski, Barry Gidal, Kevan VanLandingham, David Critchley, Gilmour Morrison
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs. Epilepsia 61 (9) (2020)